Pharmaceutical company Spectrum Thea has linked up with Aston University to monitor the use and impact of a variety of anterior and adnexal products through a Knowledge Transfer Partnership (KTP).
The aim is to keep staff and students up to date on product developments and provide clinical information on conditions such as blepharitis, dry eye and disease where nutritional supplementation may have an effect.
A statement added that the partnership gives the team at Aston an opportunity to bring the subject of ophthalmic nutrition and the growing medical conditions it can alleviate to a wider audience.
Dr Hannah Bartlett, lead academic on the project, said: 'This partnership provides a unique opportunity to translate our research into the role of nutritional supplementation for ocular disease into practical support for Spectrum Thea, eye care professionals, and patients.'
